Valković, T., Babarović, E., Lučin, K., Štifter, S., Aralica, M., Seili Bekafigo, I. ... Jonjić, N. (2016). Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma. BioMed Research International, 2016., 1-7. doi: 10.1155/2016/7870590
Valković, Toni, et al. "Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma." BioMed Research International, vol. 2016, 2016, str. 1-7. https://doi.org/10.1155/2016/7870590
Valković, Toni, Emina Babarović, Ksenija Lučin, Sanja Štifter, Merica Aralica, Irena Seili Bekafigo, Antica Duletić Načinović i Nives Jonjić. "Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma." BioMed Research International 2016 (2016): 1-7. https://doi.org/10.1155/2016/7870590
Valković, T., et al. (2016) 'Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma', BioMed Research International, 2016, str. 1-7. doi: 10.1155/2016/7870590
Valković T, Babarović E, Lučin K, Štifter S, Aralica M, Seili Bekafigo I, i sur.. Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma. BioMed Research International [Internet]. 2016. [pristupljeno 01.09.2024.];2016:1-7. doi: 10.1155/2016/7870590
T. Valković, et al., "Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma", BioMed Research International, vol. 2016, str. 1-7, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:575434. [Citirano: 01.09.2024.]